Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial

Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial

Objectives Some patients with SLE or Gougerot-Sjögren’s disease (GSD) receive long-term treatment with hydroxychloroquine (HCQ), sometimes combined with immunosuppressive therapy (IS). This study sought to assess whether long-term HCQ therapy that had been initiated long before the COVID-19 pandemic...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrice Cacoub, David Ribes, Laurent Alric, Dominique Chauveau, Grégory Pugnet, Laurent Sailler, Estibaliz Lazaro, Martin Michaud, Marion Migueres, Mathieu Vautier, Kim Ly, Anne Laure Fauchais, Emilie Berard, Morgane Mourguet, Clara Brusq, Stephanie Faure, Pascal Lebray, Jean François Viallard, Carle Paul, Arnaud Constatin, Adeline Ruysen Wittrand, Marie Irles Depe
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/12/1/e001435.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://lupus.bmj.com/content/12/1/e001435.full

Similar Items